University of Chicago Pritzker School of Molecular Engineering
The Pritzker School of Molecular Engineering integrates science and engineering to address global challenges from the molecular level up. The school is the leading catalyst for the University of Chicago’s science community. The only school of its kind in the nation, PME is organized by research themes seeking to address some of humanity’s biggest challenges. The school offers an interdisciplinary education focused on: sustainability – including water and energy; immunoengineering – centered on health; and quantum – focused on driving quantum technologies such as quantum sensing, encryption, and computing. A fourth theme, STAGE, looks at the intersection of art and science. Faculty expertise spans eight scientific and engineering disciplines.
Pengju Li, University of Chicago Pritzker School of Molecular Engineering
Researchers designed an ultrathin pacemaker that can be implanted via minimally invasive techniques, potentially improving recovery time and reducing the risk of complications.
Huanhuan Joyce Chen, University of Chicago Pritzker School of Molecular Engineering and Abhimanyu Thakur, University of Chicago Pritzker School of Molecular Engineering
De nombreuses tumeurs contiennent des cellules souches cancéreuses qui les aident à se développer et à échapper aux traitements. Une nouvelle piste tente de rendre ces cellules à nouveau normales.
Huanhuan Joyce Chen, University of Chicago Pritzker School of Molecular Engineering and Abhimanyu Thakur, University of Chicago Pritzker School of Molecular Engineering
Many tumors have cancer stem cells that help them grow and evade treatments. Differentiation therapy forces these cells to mature, stopping growth with less toxicity than traditional treatments.
Sihong Wang, University of Chicago Pritzker School of Molecular Engineering
A type of computer chip that mimics both the skin and brain could pave the way for wearable devices that monitor and analyze health data using AI right on the body.
Aslan Mansurov, University of Chicago Pritzker School of Molecular Engineering
One promising cancer treatment has been in the works for decades, but severe side effects have kept it out of the clinic. A reengineered version may offer a way to safely harness its potent effects.